Skip to main content

1 Result(s)

within Yunzhao Zhao Remove this filter Pharmacology/Toxicology Remove this filter Pharmacotherapy Remove this filter

and

  1. No Access

    Article

    Incidence and Risk of Hypertension with Ramucirumab in Cancer Patients: A Meta-Analysis of Published Studies

    Ramucirumab is a novel antiangiogenic agent approved as second-line therapy for patients with advanced stomach cancer and gastroesophageal junction adenocarcinoma. Although existing evidence from clinical tria...

    Jianhua Wang, Zexing Wang, Yunzhao Zhao in Clinical Drug Investigation (2015)